NCT01169818 Evaluation of the Effectiveness and Safety of Physician Versus Patient-led of Insulin Glargine Initiation and Titration in Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE4
NCT01169779 Efficacy and Safety of Lixisenatide in Patients With Type 2 Diabetes Mellitus Insufficiently Controlled by Metformin Status COMPLETED Phase PHASE3
NCT01163942 Randomized Study In Severe Aplastic Anemia Patients Receiving Atg, Cyclosporin A, With Or Without G-CSF (SAA-G-CSF) Status TERMINATED Phase PHASE3
NCT01162486 Pharmacokinetics, Safety and Tolerability of Escalating Rifapentine Doses in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01161836 An Open-label Study Investigating the Disposition and QT/QTc Interval Effects of 400 mg [14C]-Iniparib(3.7 MBq, 100 µCi) Status COMPLETED Phase PHASE1
NCT01161082 Ascending Multi-dose Study of REGN727(SAR236553) With and Without Concomitant Atorvastatin Status COMPLETED Phase PHASE1
NCT01160991 Effect of Atypical Antipsychotic Drugs Olanzapine and Amisulpride on Glucose Metabolism Status COMPLETED Phase NA
NCT01160419 Multicenter Study to Perioperative Chemotherapy for Resectable Adenocarcinoma in Gastric Cancer Status UNKNOWN Phase PHASE2
NCT01159353 Pharmacodynamic and Pharmacokinetic Effects of Insulin Glulisine in Obese Subjects With Type 2 Diabetes After a Standard Meal in Comparison to Insulin Aspart Status COMPLETED Phase PHASE1
NCT01157871 Dose-finding, Safety and Efficacy Study of NV1FGF in Patients With Intermittent Claudication Status COMPLETED Phase PHASE2
NCT01157156 Safety and Tolerability of NV1FGF in Patients With Severe Peripheral Artery Occlusive Disease Status COMPLETED Phase PHASE1
NCT01157143 Gene Expression and Tolerability Study of NV1FGF in Patients With Peripheral Artery Occlusive Disease Planned to Undergo Major Amputation Status COMPLETED Phase PHASE1
NCT01156870 First in Man Study of SAR566658 Administered in Patients With CA6-Positive and Refractory Solid Tumor Status COMPLETED Phase PHASE1
NCT01154153 Nasacort AQ Hypothalamic-Pituitary-Adrenal (HPA) Axis Study in Children With Allergic Rhinitis Status COMPLETED Phase PHASE4
NCT01153100 Effectiveness of Adding Subcutaneous Long-acting Glargine to Insulin Drip Therapy Compared With Standard Insulin Drip Therapy Status COMPLETED Phase PHASE1
NCT01151137 Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy Status TERMINATED Phase PHASE3
NCT01148615 A Study of Intravenous Aflibercept With Docetaxel in Chinese Patients With Solid Tumors Status COMPLETED Phase PHASE1
NCT01147250 Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide) Status COMPLETED Phase PHASE3
NCT01146678 Relative Bioavailability and Activity of Different Formulations of Insulin Glargine and Lixisenatide in Patients With Diabetes Mellitus Type 1 Status COMPLETED Phase PHASE1